Clinical trial
A Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of the Head and Neck
NCT01275183 is registered in ClinicalTrials.gov with New Mexico Cancer Research Alliance as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of the Head and Neck
- Lead sponsor
- New Mexico Cancer Research Alliance
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 2010
- Completion date
- April 30, 2015
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
head and neck cancer